Key result
Medicaid beneficiaries with schizophrenia had significantly higher odds of 30-day unplanned readmission following medical hospitalization compared to those with no SMI (aOR 1.46; 95% CI 1.33-1.59).
Why the study?
Most studies of 30-day readmissions after medical hospitalizations among adults with serious mental illness focus on privately insured or Medicare patients, with little known about the differential experiences of Medicaid beneficiaries with schizophrenia, bipolar disorder, and major depression.
Do Medicaid beneficiaries with schizophrenia, bipolar disorder, or major depressive disorder have higher rates of 30-day readmission after medical hospitalization compared to those without serious mental illness?
Cohort (n=43,817)
Yes
Do Medicaid beneficiaries with schizophrenia, bipolar disorder, or major depressive disorder have higher rates of 30-day readmission after medical hospitalization compared to those without serious mental illness?
Odds Ratio: 1.46 (95% CI 1.33–1.59)
Low-income, working-age adults with serious mental illness, particularly schizophrenia, have a significantly elevated risk of 30-day hospital readmission following medical hospitalizations.
Schizophrenia linked to highest readmission odds post-medical admission; leaves open whether targeted interventions improve outcomes in Medicaid patients.
While evidence suggests that adults with serious mental illness have an elevated rate of 30-day readmissions after medical hospitalizations, most studies are of patients who are privately insured or Medicare beneficiaries, and little is known about the differential experiences of people with schizophrenia, bipolar disorder, and major depression. We used the Truven Health Analytics MarketScan® Medicaid Multi-State Database to study 43,817 Medicaid enrollees from 11 states, age 18-64, who were discharged from medical hospitalizations in 2011. Our outcome was unplanned all-cause readmissions within 30 days of discharge. In a multivariable analysis, compared to those with no SMI, people with schizophrenia had the highest odds of 30-day readmission (aOR: 1.46, 95% CI: 1.33-1.59), followed by those with bipolar disorder (aOR: 1.25, 95% CI: 1.14-1.38), and those with major depressive disorder (aOR: 1.18, 95% CI: 1.06-1.30). Readmissions also were more likely among those with substance use disorders, males, those with Medicaid eligibility due to disability, patients with longer index hospitalizations, and those with 2 or more medical co-morbidities. This is the first large-scale study to demonstrate the elevated risk of hospital readmission among low-income, working-age adults with schizophrenia. Given their greater psychological, social, and economic vulnerability, our findings can be used to design transition interventions and service delivery systems that address their complex needs.
No takes yet. Share an insight, caveat, or question.
Cook et al. (2020) conducted a cohort in Serious mental illness (schizophrenia, bipolar disorder, major depressive disorder) (n=43,817). Schizophrenia vs. No serious mental illness (SMI) was evaluated on Unplanned all-cause readmissions within 30 days of discharge (aOR 1.46, 95% CI 1.33-1.59). Medicaid beneficiaries with schizophrenia had significantly higher odds of 30-day unplanned readmission following medical hospitalization compared to those with no SMI (aOR 1.46; 95% CI 1.33-1.59).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: